Retatrutide is a triple receptor agonist that targets the receptors of GIP, GLP-1, and glucagon hormones. By combining the effects of native GIP and GLP-1 with glucagon receptor activation, it exerts a broad appetite-suppressing and metabolic impact. Researchers suggest that this triple mechanism may offer more effective glycemic control and weight loss compared to other incretin-based therapies.


NetPeps offers products solely for research and development purposes, not for human consumption, medical, or therapeutic applications. Our products should not be misconstrued or substituted as prescription drugs. We do not dispense any prescription medications and are not a pharmacy. The US Food and Drug Administration has not assessed the assertions made on our website. Products are not intended to diagnose, treat, cure, or prevent any medical conditions or diseases.